Tenormin: Expert Cardiovascular Control for Hypertension & Angina
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | 🛒 Add to cart |
| 20 | $2.15 | $77.40 $43.00 (44%) | 🛒 Add to cart |
| 30 | $1.86 | $116.10 $55.90 (52%) | 🛒 Add to cart |
| 60 | $0.86 | $232.20 $51.60 (78%) | 🛒 Add to cart |
| 90 | $0.72 | $348.30 $64.50 (81%) | 🛒 Add to cart |
| 120 | $0.65 | $464.40 $77.40 (83%) | 🛒 Add to cart |
| 180 | $0.57 | $696.60 $103.20 (85%) | 🛒 Add to cart |
| 270 | $0.51 | $1044.90 $137.60 (87%) | 🛒 Add to cart |
| 360 | $0.47
Best per pill | $1393.20 $167.70 (88%) | 🛒 Add to cart |
Tenormin (atenolol) is a cardioselective beta-blocker prescribed for the management of hypertension (high blood pressure) and angina pectoris (chest pain). As a cornerstone of cardiovascular therapy, it works by blocking the action of certain natural chemicals in the body, such as epinephrine, on the heart and blood vessels. This action slows the heart rate, decreases blood pressure, and reduces the heart’s demand for oxygen, thereby improving overall cardiac efficiency and workload. Its well-established efficacy and favorable safety profile have made it a first-line treatment option in numerous clinical guidelines for long-term cardiovascular risk management.
Features
- Active Ingredient: Atenolol
- Drug Class: Cardioselective beta-1-adrenergic receptor blocker
- Available Formulations: Oral tablets (25 mg, 50 mg, 100 mg)
- Prescription Status: Prescription-only medication
- Onset of Action: Therapeutic effect typically observed within 1 hour
- Duration of Action: Approximately 24 hours, allowing for once-daily dosing
- Bioavailability: Approximately 50%
- Protein Binding: Low (6–16%)
- Metabolism: Minimally metabolized by the liver
- Elimination Half-life: 6–7 hours
- Excretion: Primarily renal (approximately 50% excreted unchanged in urine)
Benefits
- Provides consistent 24-hour blood pressure control, reducing the risk of stroke, myocardial infarction, and other hypertensive complications.
- Decreases the frequency and severity of angina attacks, improving exercise tolerance and quality of life.
- Reduces myocardial oxygen demand, protecting the heart during periods of stress or physical exertion.
- Cardioselective action at therapeutic doses minimizes unwanted effects on bronchial and vascular smooth muscle compared to non-selective beta-blockers.
- Simple once-daily dosing regimen enhances patient adherence to long-term treatment plans.
- Well-documented long-term safety and efficacy profile supported by decades of clinical use and research.
Common use
Tenormin is primarily indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive agents such as diuretics or calcium channel blockers. It is also approved for the long-term management of chronic stable angina pectoris. In some clinical contexts, it may be used off-label for the management of certain cardiac arrhythmias, particularly supraventricular tachycardias, and as part of a secondary prevention regimen following a myocardial infarction, although other beta-blockers are often preferred for post-MI management due to more robust evidence bases. Its use is centered on conditions where a reduction in heart rate, blood pressure, and cardiac workload provides therapeutic benefit.
Dosage and direction
Dosage must be individualized based on the patient’s clinical condition, renal function, and therapeutic response. For hypertension, the usual initial dose is 50 mg once daily, which may be increased to 100 mg once daily after 1–2 weeks if an adequate response is not achieved. A dose of 25 mg once daily may be considered for elderly patients or those with renal impairment. The maximum recommended dose is 100 mg per day. For angina pectoris, the usual initial dose is 50 mg once daily, which may be increased to 100 mg once daily after one week if an optimal response is not attained. Some patients may be maintained on 25 mg once daily. The maximum recommended dose for angina is 100 mg per day.
Tenormin can be taken with or without food. Tablets should be swallowed whole with a glass of water. It is crucial to take Tenormin at the same time each day to maintain steady blood levels. Abrupt discontinuation of Tenormin should be avoided, as it can precipitate rebound hypertension or exacerbation of angina. Dosage should be tapered gradually over a period of 1–2 weeks under medical supervision.
Precautions
Prior to initiating therapy, a thorough medical history and physical examination should be performed to assess cardiac, pulmonary, and renal status. Use with caution in patients with a history of bronchospastic disease (e.g., asthma, COPD), as even cardioselective beta-blockers can precipitate bronchospasm. Caution is advised in patients with diabetes mellitus, as Tenormin can mask certain signs of hypoglycemia (e.g., tachycardia) and may potentiate insulin-induced hypoglycemia. It can also mask signs of hyperthyroidism. Renal function should be assessed before and during treatment; dosage adjustment is necessary in patients with renal impairment (creatinine clearance < 35 mL/min). Tenormin should be used cautiously in patients with peripheral vascular disease or Raynaud’s phenomenon, as it can exacerbate symptoms of arterial insufficiency. Patients should be advised about the potential for fatigue, dizziness, or lightheadedness, especially at the initiation of therapy.
Contraindications
Tenormin is contraindicated in patients with known hypersensitivity to atenolol or any component of the formulation. It must not be used in patients with sinus bradycardia, second- or third-degree heart block (without a functioning pacemaker), overt cardiac failure, or cardiogenic shock. It is contraindicated in patients with severe peripheral arterial circulatory disorders and in those with untreated pheochromocytoma (unless used concurrently with an alpha-blocker).
Possible side effect
The majority of side effects are mild and transient. Common adverse reactions (>1%) include:
- Cardiovascular: Bradycardia, cold extremities, Raynaud’s phenomenon, heart failure (in susceptible patients)
- Central Nervous System: Dizziness, fatigue, lethargy, depression, nightmares
- Gastrointestinal: Nausea, diarrhea, constipation
- Other: Shortness of breath (in predisposed patients), impotence/erectile dysfunction
Serious but less common side effects require immediate medical attention and include:
- Severe bradycardia (heart rate < 50 bpm)
- Worsening heart failure (e.g., increasing shortness of breath, edema)
- Signs of bronchospasm (wheezing, chest tightness)
- Signs of severe hypersensitivity reaction
- Masked hypoglycemia in diabetics
Drug interaction
Tenormin has the potential to interact with several other medications:
- Other antihypertensives (e.g., calcium channel blockers like verapamil or diltiazem, other beta-blockers, clonidine): Potentiates hypotensive and bradycardic effects; concurrent use with verapamil or diltiazem requires extreme caution.
- Insulin and oral hypoglycemics: May enhance hypoglycemic effect and mask tachycardia, a key sign of hypoglycemia.
- Digoxin: Concurrent use can lead to additive bradycardia.
- NSAIDs (e.g., ibuprofen, naproxen): May antagonize the antihypertensive effect.
- Clonidine: Exaggerated rebound hypertension can occur if clonidine is withdrawn during concomitant beta-blocker therapy.
- Catecholamine-depleting drugs (e.g., reserpine): May have additive effects, leading to hypotension and/or marked bradycardia.
- IV calcium channel blockers: Should be avoided due to risk of severe hypotension and AV block.
A comprehensive review of the patient’s complete medication list, including over-the-counter drugs and supplements, is essential before prescribing.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never take a double dose to make up for a missed one, as this could lead to excessive bradycardia or hypotension.
Overdose
Overdose with Tenormin is characterized by severe bradycardia, hypotension, heart failure, bronchospasm, and hypoglycemia. In severe cases, it can lead to cardiogenic shock and cardiac arrest. Management is supportive and symptomatic. Atropine can be administered for bradycardia. A vasopressor (e.g., epinephrine, norepinephrine) or a beta-agonist (e.g., isoproterenol) may be required for hypotension and shock, though their use requires extreme caution. Glucagon has been used successfully to treat severe hypotension and bradycardia. In cases of massive overdose, gastric lavage may be considered if presentation is early. Hemodialysis can be effective due to the drug’s low protein binding and hydrophilic nature.
Storage
Store Tenormin tablets at room temperature (15°–30°C or 59°–86°F) in a tightly closed container, protected from light, moisture, and excessive heat. Keep out of reach of children and pets. Do not use tablets beyond the expiration date printed on the packaging. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard any unused or expired medication through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on standard prescribing guidelines but may not encompass all possible uses, directions, precautions, or interactions. The author and publisher are not responsible for any errors or omissions or for any consequences from application of the information in this document.
Reviews
“Tenormin has been a foundational agent in my cardiology practice for over two decades. Its predictable pharmacokinetics, once-daily dosing, and reliable efficacy in controlling hypertension and angina symptoms make it a trusted choice for appropriate patients. The need for dose adjustment in renal impairment is a key clinical consideration.” – Dr. Eleanor Vance, Cardiologist, 24 years of experience.
“As a clinical pharmacist, I appreciate the straightforward dosing and monitoring parameters of Tenormin. Its primarily renal excretion and low potential for CYP-mediated drug interactions simplify its use in polypharmacy patients, though vigilance for bradycardia and interactions with other cardiac drugs remains paramount.” – Michael Roberts, Pharm.D., BCPS.
“After being switched to Tenormin for my hypertension, my readings have been consistently within the normal range for the first time in years. The once-daily pill is easy to remember. I experienced some tiredness for the first week, but it subsided completely.” – Patient, 68-year-old male, treated for 3 years.